Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ru-Yi X"'
Autor:
Xia-Hui Lin, Dong-ping Li, Zhi-Yong Liu, Si Zhang, Wen-qing Tang, Rong-xin Chen, Shu-qiang Weng, Yu-jen Tseng, Ru-yi Xue, Ling Dong
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-20 (2023)
Abstract Background Abnormal miRNA and mRNA expression and dysregulated immune microenvironment have been found to frequently induce the progression of hepatocellular carcinoma (HCC) in recent reports. In particular, the immune-related competing endo
Externí odkaz:
https://doaj.org/article/b884d597764c49a8967e933a458f38bb
Autor:
Xia-Hui Lin, Zhi-Yong Liu, Dan-Ying Zhang, Si Zhang, Wen-Qing Tang, Dong-Ping Li, Feng Zhang, Rong-Xin Chen, Shu-Qiang Weng, Ru-Yi Xue, Ling Dong
Publikováno v:
Experimental Hematology & Oncology, Vol 11, Iss 1, Pp 1-21 (2022)
Abstract Background Though circular RNAs (circRNAs) are the key regulators in tumor carcinogenesis, they remain largely unexplored in hepatocellular carcinoma (HCC). Methods The expression of RanGAP1-derived circRNAs (circ_0063531, circ_0063534, circ
Externí odkaz:
https://doaj.org/article/d1fb2f7f57084b5d83306be6825f33a0
Autor:
Hui-miao Sun, Qian-yun Li, Ru-yi Xiao, Ze-dong Zhang, Xiao-yan Yang, Jie Yang, Bo Jin, Jia-xiang Wen, Yan-jun Wu, Hong Yang, Fan Wang
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
ObjectiveTo use structural magnetic resonance imaging (3D-MRI) to evaluate the abnormal development of the cerebral cortex in infants with global developmental delay (GDD).MethodsThe GDD group includes 67 infants aged between 112 and 699 days with gl
Externí odkaz:
https://doaj.org/article/9ac6ad4e7f324732a376704c05b15b8b
Autor:
Ke-Xin Sun, Bin Cui, Shan-Shan Cao, Qi-Xiang Huang, Ru-Yi Xia, Wen-Jun Wang, Jing-Wen Wang, Feng Yu, Yi Ding
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: The drug therapy of venous thromboembolism (VTE) presents a significant economic burden to the health-care system in low- and middle-income countries. To understand which anticoagulation therapy is most cost-effective for clinical decisio
Externí odkaz:
https://doaj.org/article/828aa36d8b8d4c309ff7c2121a05501c
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a2663bd6adf16557153075036c6318e3
http://www.scopus.com/inward/record.url?eid=2-s2.0-78751531715&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-78751531715&partnerID=MN8TOARS
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
An J; Zhengzhou Key Laboratory of Antitumor Traditional Chinese Medicine Research, Medical College, Huanghe Science & Technology College, Zhengzhou, China/School of Pharmacy, Henan University, KaiFeng, PR China., Xiao-Ying M, Xiao-Qiang H; Zhengzhou Key Laboratory of Antitumor Traditional Chinese Medicine Research, Medical College, Huanghe Science & Technology College, Zhengzhou, China., Shun-He L; Zhengzhou Key Laboratory of Antitumor Traditional Chinese Medicine Research, Medical College, Huanghe Science & Technology College, Zhengzhou, China., Xin W; Zhengzhou Key Laboratory of Antitumor Traditional Chinese Medicine Research, Medical College, Huanghe Science & Technology College, Zhengzhou, China., De-Quan X; School of Pharmacy, Henan University, KaiFeng, PR China., Ru-Yi X; Henan Xiangshi Yaofang BEN CAO PHARMA Co., Ltd., PR China.
Publikováno v:
Pakistan journal of pharmaceutical sciences [Pak J Pharm Sci] 2024 May; Vol. 37 (3), pp. 563-569.